FORT MYERS, Fla., Jan. 15, 2026 (GLOBE NEWSWIRE) — American Oncology Research, LLC (AOR) and Meaningful Insights Biotech Analytics, LLC (MiBA) announced a strategic partnership to align community oncology site management with AI-enhanced data intelligence. The collaboration integrates AOR’s site management capabilities with MiBA’s real-world data and AI platform to streamline study design, site feasibility and patient access across the American Oncology Network (AON).
The partners said the effort aims to address the disconnect between static clinical trial protocols and the dynamic realities of patient care by embedding intelligent data workflows into clinical operations. The integrated model is designed to shift research from a reactive administrative process to a proactive, data-informed discipline that identifies and resolves operational friction points earlier in the research lifecycle.
“To truly advance patient care, we must modernize the infrastructure that supports it,” said Katie Goodman, vice president of research at American Oncology Research. “Our partnership with MiBA moves beyond traditional site management by operationalizing real-time data. This allows us to identify friction points before they occur—whether in feasibility, startup or enrollment—ensuring that the speed of research matches the urgency of our patients’ needs.”
Using MiBA’s real-world data capabilities, AOR will perform feasibility analyses and patient matching based on contemporaneous network data, providing near-real-time views of eligible patient populations. The partners said this will help validate site viability, prioritize resource allocation and shorten the timeline from site selection to patient enrollment.
“Integrating real-time data into community research is essential to closing the gap between trial availability and patient need,” said Ralph V. Boccia, MD, medical director of American Oncology Research. “This partnership strengthens our ability to identify eligible patients sooner, open trials more efficiently and ensure that life-changing therapies are accessible to individuals receiving care close to home.”
“The future of clinical development relies on the seamless convergence of care and research,” said Mark Moch, managing partner at MiBA. “By embedding AI-powered intelligence into AOR’s clinical workflows, we are not just identifying patients; we are architecting a system where trials are accessible, efficient and aligned with the provider’s daily workflow.”
A key component of the initiative is integrating research opportunities into the point of care. The platform will surface targeted trial insights within the electronic medical record (EMR) environment to increase oncologist awareness and present trials as immediate care options. The partners also said the data-driven approach will support Diversity Action Plan (DAP) goals by identifying demographic barriers early and enabling inclusive enrollment strategies during study design, reducing the need for protocol amendments and improving representativeness.
About American Oncology Research
American Oncology Research helps community practices offer clinical trials with tailored site management services, regulatory support, patient recruitment and operational tools to expand local access to investigational therapies.
About Meaningful Insights Biotech Analytics
Meaningful Insights Biotech Analytics is a healthcare AI company that provides real-world data and analytics to support pharmaceutical companies, research organizations, health systems and providers in improving patient care and research efficiency. More information is available at www.mibaanalytics.com.
About American Oncology Network
American Oncology Network (AON) is a physician-led alliance of community oncology providers and leaders that supports practice sustainability, value-based care and expanded access to cancer treatment across more than 20 states.
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/769aca83-d193-4ea7-8d2c-0d7daf06ca6a
Contact: Karen Riley Sawyer, American Oncology Network, [email protected]
Leave a Reply